Pacific6 Enterprises and JM Molina Investments Announce a Joint Investment in Detact Diagnostics

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

December 18, 2020

Pacific6 Enterprises and JM Molina Investments, today announced a joint investment to acquire a 33% interest in Detact Diagnostics™, a Netherlands-based life-science company.

Pacific6 is an investment partnership founded, in part, by John Molina, the former CFO of Molina Healthcare. His brother, J. Mario Molina, M.D., former CEO of Molina Healthcare, is the principal behind JM Molina Investments.

Detact Diagnostics™, founded in 2014 by former trauma surgeon Joost Gazendam, specializes in the development of bacterial and viral detection technologies. The company’s innovative, patented technique can accurately and reliably detect the presence of a bacteria or virus within minutes. This proprietary detection platform – uniquely suited to developing quick, affordable, point of care tests – serves as the foundation for the company’s current development of a rapid Covid-19 screening test, CoviTact©.

The novel CoviTact© saliva screening test is low-cost and requires no laboratory processing nor trained clinical staff to administer, and yields results in under two minutes – making it ideal for strategic deployment at venues worldwide.

“Joost and his team have been laser-focused on creating an innovative, disruptive diagnostic technology,” said John Molina, Founding Partner at Pacific6. “This investment will extend our company’s international reach and help accelerate the development of affordable, reliable testing technologies that will dramatically change the rapid-test landscape.”

“We couldn’t be more enthusiastic to partner with the Molinas,” said Dr. Joost Gazendam, CEO of Detact Diagnostics. “They share our vision for healthy living and we’re excited to have a partner that not only provides funding but also brings a vast amount of experience as a leader in the healthcare industry.”



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.